UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 61

Sortiert nach

Long-term treatment with oral N-acetylcysteine: Affects lung function but not sputum inflammation in cystic fibrosis subjects. A phase II randomized placebo-controlled trial

Journal of cystic fibrosis, 2015-03, Vol.14 (2), p.219-227

2015

Volltextzugriff (PDF)

DAS181 treatment of severe parainfluenza type 3 pneumonia in a lung transplant recipient

Transplant infectious disease, 2013-02, Vol.15 (1), p.E28-E32

2013

Volltextzugriff (PDF)

WS04.2 Improvement in inflammatory biomarkers in patients (pts) with cystic fibrosis (CF) homozygous for the F508del-CFTR mutation treated with lumacaftor (LUM) and ivacaftor (IVA)

Journal of cystic fibrosis, 2016-06, Vol.15, p.S6-S6

2016

Volltextzugriff (PDF)

54 Relationship between rate of percent predicted FEV1 (ppFEV1 ) decline and baseline and acute change in ppFEV1 in patients (pts) with cystic fibrosis (CF) treated with lumacaftor/ivacaftor (LUM/IVA)

Journal of cystic fibrosis, 2017-06, Vol.16, p.S78-S78

2017

Volltextzugriff (PDF)

EPS4.3 Differential sensitivity of outcome measures that assess progression of mild CF lung disease in school age children

Journal of cystic fibrosis, 2017-06, Vol.16, p.S44-S45

2017

Volltextzugriff (PDF)

WS23.6 Ivacaftor treatment in patients with cystic fibrosis who have an R117H-CFTR mutation, the KONDUCT study

Journal of cystic fibrosis, 2014-06, Vol.13, p.S44-S44

2014

Volltextzugriff (PDF)

WS22.1 Basophil activation is a reliable biomarker of allergic bronchopulmonary aspergillosis (ABPA) in CF: Interim results of a longitudinal cohort study

Journal of cystic fibrosis, 2013-06, Vol.12, p.S46-S46

2013

Volltextzugriff (PDF)

WS9.7 Modulatory effects of Aspergillus colonization and ABPA on blood and sputum eosinophils and neutrophils in CF

Journal of cystic fibrosis, 2012-06, Vol.11, p.S20-S20

2012

Volltextzugriff (PDF)

184 Basophil CD203c as a potential clinically relevant biomarker in cystic fibrosis and allergic bronchopulmonary aspergillosis

Journal of cystic fibrosis, 2011, Vol.10, p.S46-S46

2011

Volltextzugriff (PDF)

Study Of Sublingual Immunotherapy In Subjects With Dermatophagoides Farniae And Timothy Grass Allergy

Journal of allergy and clinical immunology, 2009-02, Vol.123 (2), p.S126-S126

2009

Volltextzugriff (PDF)

P107 ECFS/CFF global survey on diagnosis and treatment of Aspergillus fumigatus-related conditions

Journal of cystic fibrosis, 2020-06, Vol.19, p.S85-S86

2020

Volltextzugriff (PDF)

Aerosol and pharmacokinetic properties of denufosol support its use for early intervention in CF lung disease

Journal of cystic fibrosis, 2010, Vol.9, p.S21-S21

2010

Volltextzugriff (PDF)

Denufosol improves lung function in adolescent CF patients

Journal of cystic fibrosis, 2010, Vol.9, p.S20-S20

2010

Volltextzugriff (PDF)

Improvement in ion transport biomarkers and spirometry with the investigational CFTR potentiator VX-770 in subjects with cystic fibrosis and the G551D-CFTR mutation

Paediatric respiratory reviews, 2010, Vol.11, p.S99-S99

2010

Volltextzugriff (PDF)

DAS181 treatment of hematopoietic stem cell transplant patients with parainfluenza virus lung disease requiring mechanical ventilation

Transplant infectious disease, 2014-02, Vol.16 (1), p.141-144

2014

Volltextzugriff (PDF)

A phase I study of aerosolized administration of tgAAVCF to cystic fibrosis subjects with mild lung disease

Human gene therapy, 2001-10, Vol.12 (15), p.1907-1916

2001

Volltextzugriff (PDF)

DAS 181 treatment of hematopoietic stem cell transplant patients with parainfluenza virus lung disease requiring mechanical ventilation

Transplant infectious disease, 2014-02, Vol.16 (1), p.141-144

2014

Volltextzugriff (PDF)

DAS 181 treatment of severe parainfluenza type 3 pneumonia in a lung transplant recipient

Transplant infectious disease, 2013-02, Vol.15 (1)

2013

Volltextzugriff (PDF)

DAS181 Treatment of Severe Parainfluenza Virus 3 Pneumonia in Allogeneic Hematopoietic Stem Cell Transplant Recipients Requiring Mechanical Ventilation

Case reports in medicine, 2016-01, Vol.2016, p.8503275-4

2016

Volltextzugriff (PDF)

Inhibition of Airway Inflammation by TIM-1 Antibody in a Murine Model of Asthma

Journal of allergy and clinical immunology, 2005-04, Vol.115 (4), p.891-891

2005

Volltextzugriff (PDF)

HIV-1-Specific Functional Immune Measurements as Markers of Disease Progression

Journal of biomedical science, 1997-07, Vol.4 (4), p.127-131

1997

Volltextzugriff (PDF)

Activation of CFTR chloride current by nitric oxide in human T lymphocytes

The EMBO journal, 1995-06, Vol.14 (12), p.2700-2707

1995

Volltextzugriff (PDF)

Current treatment options for invasive aspergillosis

Drugs of today (Barcelona, Spain : 1998), 2013-03, Vol.49 (3), p.213-226

2013

Volltextzugriff (PDF)

Sinus disease in patients with severe cystic fibrosis: relation to pulmonary exacerbation

The Lancet (British edition), 1990-05, Vol.335 (8697), p.1077-1078

1990

Volltextzugriff (PDF)

Clinical protocol: AAV-CFTR for the treatment of chronic sinusitis in CF patients

Clinical pharmacology and therapeutics, 1996-02, Vol.59 (2), p.174-174

1996

Volltextzugriff (PDF)

1 – 25 von 61

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(47)
Mit Volltextzugriff
(52)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(27)
Life Sciences & Biomedicine
(19)
Humans
(12)
Female
(11)
Pulmonary/respiratory
(11)
Male
(10)
Physical Sciences
(8)
Adult
(7)
Biological And Medical Sciences
(7)
Physics
(7)
Medical Sciences
(5)
Middle Aged
(5)
Aged
(4)
Astronomy & Astrophysics
(4)
Das181
(4)
Immunology
(4)
Parainfluenza
(4)
Physics, Particles & Fields
(4)
Radiology, Nuclear Medicine & Medical Imaging
(4)
Technology
(4)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Long-term treatment with oral N-acetylcysteine: Affects lung function but not sputum inflammation in cystic fibrosis subjects. A phase II randomized placebo-controlled trial

DAS181 treatment of severe parainfluenza type 3 pneumonia in a lung transplant recipient

WS04.2 Improvement in inflammatory biomarkers in patients (pts) with cystic fibrosis (CF) homozygous for the F508del-CFTR mutation treated with lumacaftor (LUM) and ivacaftor (IVA)

54 Relationship between rate of percent predicted FEV1 (ppFEV1 ) decline and baseline and acute change in ppFEV1 in patients (pts) with cystic fibrosis (CF) treated with lumacaftor/ivacaftor (LUM/IVA)

EPS4.3 Differential sensitivity of outcome measures that assess progression of mild CF lung disease in school age children

WS23.6 Ivacaftor treatment in patients with cystic fibrosis who have an R117H-CFTR mutation, the KONDUCT study

WS22.1 Basophil activation is a reliable biomarker of allergic bronchopulmonary aspergillosis (ABPA) in CF: Interim results of a longitudinal cohort study

WS9.7 Modulatory effects of Aspergillus colonization and ABPA on blood and sputum eosinophils and neutrophils in CF

184 Basophil CD203c as a potential clinically relevant biomarker in cystic fibrosis and allergic bronchopulmonary aspergillosis

Study Of Sublingual Immunotherapy In Subjects With Dermatophagoides Farniae And Timothy Grass Allergy

P107 ECFS/CFF global survey on diagnosis and treatment of Aspergillus fumigatus-related conditions

Aerosol and pharmacokinetic properties of denufosol support its use for early intervention in CF lung disease

Denufosol improves lung function in adolescent CF patients

Improvement in ion transport biomarkers and spirometry with the investigational CFTR potentiator VX-770 in subjects with cystic fibrosis and the G551D-CFTR mutation

DAS181 treatment of hematopoietic stem cell transplant patients with parainfluenza virus lung disease requiring mechanical ventilation

A phase I study of aerosolized administration of tgAAVCF to cystic fibrosis subjects with mild lung disease

DAS 181 treatment of hematopoietic stem cell transplant patients with parainfluenza virus lung disease requiring mechanical ventilation

DAS 181 treatment of severe parainfluenza type 3 pneumonia in a lung transplant recipient

DAS181 Treatment of Severe Parainfluenza Virus 3 Pneumonia in Allogeneic Hematopoietic Stem Cell Transplant Recipients Requiring Mechanical Ventilation

Inhibition of Airway Inflammation by TIM-1 Antibody in a Murine Model of Asthma

HIV-1-Specific Functional Immune Measurements as Markers of Disease Progression

Activation of CFTR chloride current by nitric oxide in human T lymphocytes

Current treatment options for invasive aspergillosis

Sinus disease in patients with severe cystic fibrosis: relation to pulmonary exacerbation

Clinical protocol: AAV-CFTR for the treatment of chronic sinusitis in CF patients

Suchergebnisse filtern